Last reviewed · How we verify
STUDY00015328: Sepsis Endotypes
Determine the utility of biomarkers measured in blood and body fluid (stool, saliva, tracheal aspirate) when combined with clinical data, for predicting sepsis phenotypes that are associated with poor clinical outcomes. We hypothesize that resistin is a biomarker which provides critical prognostic information when used in conjunction with standard clinical data, in patients with sepsis and septic shock.
Details
| Lead sponsor | Milton S. Hershey Medical Center |
|---|---|
| Status | ENROLLING_BY_INVITATION |
| Enrolment | 200 |
| Start date | Thu Aug 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Jun 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Sepsis
Countries
United States